Abstract P5-19-17: Final Results of the Phase I "HIT" Study: A Multicenter Phase I-II Study Evaluating Trastuzumab Administered by Intrathecal Injection for Leptomeningeal Meningitis of HER2+ Metastatic Breast Cancer (MBC)
Cancer Research（2015）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined